Bilateral Mastectomy and Breast Cancer Mortality
This cohort study estimates the 20-year cumulative risk of breast cancer mortality among women with stage 0 to III unilateral breast cancer according to the type of initial surgery performed.
This cohort study estimates the 20-year cumulative risk of breast cancer mortality among women with stage 0 to III unilateral breast cancer according to the type of initial surgery performed.
An abstract is unavailable.
A national data analysis published by researchers from Penn Medicine reported that short-term mortality was not impacted for patients with advanced cancers during the shortage…
The one-year grant of $50,000 supports a postdoctoral or clinical research fellow conducting translational or clinical sarcoma research.
A discussion paper on the role of the clinical nurse specialist in uro-oncology noted challenges due to a lack of consistent definition of the role,…
The 2025 Tandem Meetings feature both in-person and digital programming for attendees to choose the experience that best fits their schedule, budget and needs.
Cancer Research | 85 | 1 | January 2025
Virginia G. Kaklamani, MD, DSc, discusses how effective elacestrant (Orserdu) is in CDK4/6 inhibitor-naive estrogen receptor-positive/HER2-negative metastatic breast cancer treatment.
Annals of Surgical Oncology – The Evaluation of Groin Lymphadenectomy Extent for Melanoma (EAGLE FM) study sought to address the question of whether to perform…
This study compares knowledge of diagnosis and worry among adults presented with prostate biopsy reports in a patient-centered format, which present important clinical data in…
Ellrott et al. provide a means to assign patient samples from clinical trials and other cancer genome studies to published TCGA molecular subtypes. Applying machine learning…